Evidence map›Paper›PMID 33228708›Full record

ArticleJournal of orthopaedic surgery and research2020

miR-129-3p alleviates chondrocyte apoptosis in knee joint fracture-induced osteoarthritis through CPEB1.

Ruixiong Chen, Baoqing Ye, Han Xie, Yuliang Huang, Zhehui Wu, Hongbo Wu, Xiaofeng Wang, Haixiong Miao, Weiguo Liang

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Protective effect ofToxicology reports · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. RNA binding proteins in osteoarthritis.Frontiers in cell and developmental biology · 2022
    Review
  10. Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis.Frontiers in cell and developmental biology · 2021
    Review
  11. The Mechanism Action of German Chamomile (Frontiers in pharmacology · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ruixiong ChenDepartment of Orthopedics, Guangzhou Red Cross Hospital Affiliated to Jinan University, No. 396, Mid Tongfu Road, Haizhu District, Guangzhou, 510000, Guangdong, People's Republic of China.
Baoqing YeDepartment of Orthopedics, Guangzhou Red Cross Hospital Affiliated to Jinan University, No. 396, Mid Tongfu Road, Haizhu District, Guangzhou, 510000, Guangdong, People's Republic of China.
Han XieDepartment of Orthopedics, Huizhou Central People's Hospital, Huizhou, 516000, Guangdong, People's Republic of China.
Yuliang HuangDepartment of Orthopedics, Huizhou Central People's Hospital, Huizhou, 516000, Guangdong, People's Republic of China.
Zhehui WuDepartment of Orthopedics, Huizhou Central People's Hospital, Huizhou, 516000, Guangdong, People's Republic of China.
Hongbo WuDepartment of Orthopedics, Huizhou Central People's Hospital, Huizhou, 516000, Guangdong, People's Republic of China.
Xiaofeng WangDepartment of Orthopedics, Huizhou Central People's Hospital, Huizhou, 516000, Guangdong, People's Republic of China.
Haixiong MiaoDepartment of Orthopedics, Guangzhou Red Cross Hospital Affiliated to Jinan University, No. 396, Mid Tongfu Road, Haizhu District, Guangzhou, 510000, Guangdong, People's Republic of China. miaohaixiong@163.com.
Weiguo LiangDepartment of Orthopedics, Guangzhou Red Cross Hospital Affiliated to Jinan University, No. 396, Mid Tongfu Road, Haizhu District, Guangzhou, 510000, Guangdong, People's Republic of China. liangweiguo1961@126.com.
Huizhou Central People's Hospital · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoarthritis (OA), a refractory disease, is one of the leading contributors for disability worldwide. Since chondrocyte is the only resident cell in cartilage, this study aims to explore the roles of miR-129-3p and CPEB1 in chondrocyte apoptosis in knee joint fracture-induced OA.

methodsCartilage was collected from 20 OA patients who underwent total knee replacement (OA group) and 20 patients with knee contusion (normal group). Then, miR-129-3p and CPEB1 levels in the cartilage were quantified by qRT-PCR. Primary rat chondrocytes in the knee were isolated and identified by toluidine blue staining and immunofluorescent staining of type II collagen. OA cellular models were induced by TNF-α treatment, in which miR-129-3p and CPEB1 expressions were assessed. Subsequently, cell viability, apoptosis, and the expression levels of apoptotic protein and caspase-3 were measured. Dual luciferase reporter assay identified the interaction between miR-129-3p and CPEB1.

resultsPatients in the OA group had decreased miR-129-3p expression and increased CPEB1 expression than those in the normal group. TNF-α treatment successfully induced the OA cellular model. Downregulated miR-129-3p and upregulated CPEB1 expressions were found in OA-treated chondrocytes. miR-129-3p overexpression or CPEB1 knockdown improved chondrocyte viability and attenuated apoptosis, and vice versa. miR-129-3p negatively regulated CPEB1, thus ameliorating apoptosis and enhancing cell viability.

conclusionmiR-129-3p negatively targeted CPEB1 to facilitate chondrocyte viability and hamper apoptosis.

Indexed as

AnimalsApoptosisArthroplasty, Replacement, KneeCartilage, ArticularCells, CulturedCell SurvivalChondrocytesCollagen Type IIFemaleGene ExpressionGene Expression Regulation, DevelopmentalKnee InjuriesKnee JointMaleMicroRNAsmRNA Cleavage and Polyadenylation FactorsCollagen Type IICPEB1 protein, humanMicroRNAsMirn129 microRNA, humanmRNA Cleavage and Polyadenylation FactorsTranscription FactorsCell viabilityChondrocyte apoptosisCPEB1Knee joint fracturemiR-129-3pOsteoarthritis

Identifiers

PMID33228708
PMCPMC7684967
OpenAlexW3110410714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.